Abstract:Purpose: New serum biomarkers are needed to improve the early detection of colorectal adenocarcinoma. We performed surface enhanced laser desorption and ionization time-of-flight mass spectrometry (SELDI-TOF-MS) to screen for differentially expressed proteins in serum and build a proteomic diagnostic pattern for the detection of colorectal adenocarcinoma to improve the prognosis of patients with this disease. Experimental Design: In an attempt to improve current approaches to the serologic diagnosis of colorectal cancer, we analyzed serum samples from subjects with or without colorectal cancer using SELDI-MS. Using a case-control study design, SELDI-MS profile of serum samples from 74 colorectal adenocarcinoma patients were compared with 48 age-and sex-matched healthy subjects using a ProteinChip reader, PBSII-C. Proteomic MS spectra were generated using IMAC3 chips, and protein peaks clustering and classification analyses were performed to build a proteomic pattern that could differentiate patients with colorectal adenocarcinoma from healthy subjects utilizing Biomarker Wizard and Biomarker Patterns software packages, respectively. The constructed pattern was then used to test an independent set of masked serum samples from 60 colorectal cancer patients and 39 healthy subjects.Results: Among the differentially expressed protein peaks identified by SELDI-MS profiling that had the ability to distinguish between patients and healthy subjects, we determined a minimum set of two protein peaks for system training and for developing a decision classification pattern. Masked analysis of an independent set of serum samples showed the diagnostic pattern could differentiate patients with different stages of colorectal cancer from healthy subjects with a sensitivity of 95.00 percent and specificity of 94.87 percent. Conclusion: SELDI-TOF-MS profiling of serum proteins combined with bioinformatics tools can be applied to accurately differentiate patients with colorectal cancer from healthy subjects. The high sensitivity and specificity achieved by the constructed clustering analysis algorithm show great potential for the early detection of colorectal cancer.

A study on the serum proteomics in patients of colorectal cancer

Establishment of Serum Protein Pattern for Screening Colorectal Cancer Using SELDI-TOF-MS.

A Research Study of the Serum Proteomics Expressions on Liver Metastases Value in Colorectal Carcinoma

Research on the biomarkers for the prediction of efficacy in first-line chemotherapy of metastatic colorectal cancer using SELDI-TOF-MS

Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.

Identification of Serum Biomarkers for Colorectal Cancer Metastasis Using A Differential Secretome Approach

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

[Application of SELDI-TOF-MS in Detection of Liver Metastasis from Colorectal Cancer].

[Establish Predictive Model of Colorectal Cancer by Using Surface Enhanced Laser Desorption/ionization-Time of Flight-Mass Spectrometry].

Research on the differential expression of proteomics models of colorectal cancer, colorectal benign disease and healthy people

A Serum Proteomic Pattern for the Detection of Colorectal Adenocarcinoma Using Surface Enhanced Laser Desorption and Ionization Mass Spectrometry

Establishing Diagnostic Model of Serum Protein Fingerprinting Patterns for Henatic Metastasis of Coloretal Carcinoma and Its Clinical Application

Proteomic research of biomarker of colorectal cancer metastasis

Construction of the classification tree model of colorectal cancer with lymphatic metastasis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry

Proteomic analysis of expressed differentially proteins involved in human colorectal carcinomas, colorectal adenoma and normal colonic mucosa tissues

Proteomic Analysis of Differentially Expressed Proteins Between Metastatic and Non-Metastatic Human Colorectal Carcinoma Cell Lines.

Preoperatively Molecular Staging with CM10 ProteinChip and SELDI-TOF-MS for Colorectal Cancer Patients

Analysis of the difference of serum proteome profiles between breast cancer patients and heathy women

Evaluation of the Diagnostic Value of Serum-Based Proteomics for Colorectal Cancer.

Identification of Colorectal Cancer Using Proteomic Patterns in Serum

Differential Expression of Proteomics Models of Colorectal Cancer, Colorectal Benign Disease and Healthy Controls